Your browser doesn't support javascript.
loading
Identification of Oocyst-Driven Toxoplasma gondii Infections in Humans and Animals through Stage-Specific Serology-Current Status and Future Perspectives.
Álvarez García, Gema; Davidson, Rebecca; Jokelainen, Pikka; Klevar, Siv; Spano, Furio; Seeber, Frank.
Afiliación
  • Álvarez García G; Saluvet Group, Animal Health Department, Complutense University of Madrid, Ciudad Universitaria s/n, 28040 Madrid, Spain.
  • Davidson R; Department of Animal Health and Food Safety, Norwegian Veterinary Institute, 9016 Tromsø, Norway.
  • Jokelainen P; Department of Bacteria, Parasites and Fungi, Infectious Disease Preparedness, Statens Serum Institut, 2300 Copenhagen, Denmark.
  • Klevar S; Department of Analysis and Diagnostics, Norwegian Veterinary Institute, 1433 Ås, Norway.
  • Spano F; Unit of Foodborne and Neglected Parasitic Diseases, Department of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Seeber F; FG 16: Mycotic and Parasitic Agents and Mycobacteria, Robert Koch-Institut, 13353 Berlin, Germany.
Microorganisms ; 9(11)2021 Nov 13.
Article en En | MEDLINE | ID: mdl-34835471
ABSTRACT
The apicomplexan zoonotic parasite Toxoplasma gondii has three infective stages sporozoites in sporulated oocysts, which are shed in unsporulated form into the environment by infected felids; tissue cysts containing bradyzoites, and fast replicating tachyzoites that are responsible for acute toxoplasmosis. The contribution of oocysts to infections in both humans and animals is understudied despite being highly relevant. Only a few diagnostic antigens have been described to be capable of discriminating which parasite stage has caused an infection. Here we provide an extensive overview of the antigens and serological assays used to detect oocyst-driven infections in humans and animals according to the literature. In addition, we critically discuss the possibility to exploit the increasing knowledge of the T. gondii genome and the various 'omics datasets available, by applying predictive algorithms, for the identification of new oocyst-specific proteins for diagnostic purposes. Finally, we propose a workflow for how such antigens and assays based on them should be evaluated to ensure reproducible and robust results.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_zoonosis Tipo de estudio: Diagnostic_studies Idioma: En Revista: Microorganisms Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_zoonosis Tipo de estudio: Diagnostic_studies Idioma: En Revista: Microorganisms Año: 2021 Tipo del documento: Article País de afiliación: España
...